Results 141 to 150 of about 5,741 (187)
Some of the next articles are maybe not open access.
Genitourinary Syndrome of Menopause
Journal of Midwifery & Women's Health, 2021AbstractGenitourinary syndrome of menopause (GSM) occurs in approximately 50% of menopausal women but is both underrecognized and undertreated despite numerous treatment options. Vaginal dryness, irritation, dyspareunia, urinary frequency, and urinary urgency are some of the more common symptoms that can have a negative effect on women's lives and ...
Queen Henry-Okafor +3 more
openaire +3 more sources
Genitourinary Syndrome of Menopause
Medical Clinics of North America, 2023Introduced in 2014, genitourinary syndrome of menopause (GSM) describes a variety of unpleasant genital, sexual and urinary symptoms that can either be isolated or coexisting and are not related to other medical conditions. GSM is a chronic and progressive condition that requires early recognition and appropriate management to preserve urogenital ...
Shanice, Cox +3 more
openaire +2 more sources
Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause [PDF]
Sexual Medicine Reviews, 2018 Introduction Genitourinary conditions in women increase in prevalence with age. Androgens are prerequisite hormones of estrogen biosynthesis, are produced in larger amounts than estrogens in women, and decrease throughout adulthood. However, research and
Abdulmaged M Traish +2 more
exaly +4 more sources
The genitourinary syndrome of menopause
Menopause, 2021Abstract Genitourinary syndrome of menopause (GSM) refers to a collection of symptoms resulting from diminished hormonal, primarily estrogenic stimulation to the vulvovaginal or lower urinary tract and may affect up to 50% of postmenopausal women.
Nancy A, Phillips, Gloria A, Bachmann
openaire +2 more sources
Genitourinary Syndrome of Menopause in Cancer Survivors
Clinical Obstetrics & Gynecology, 2023Genitourinary syndrome of menopause (GSM) encompasses the symptoms of estrogen deprivation in the vaginal, vulva, and bladder areas. Because many cancer treatments induce a hypoestrogenic state, GSM is common in cancer survivors. The number of cancer survivors is increasing, and the unique aspects of GSM management for cancer survivors, such as the ...
Catherine L, Dugan +2 more
openaire +2 more sources
Genitourinary syndrome of menopause: the unmet need
Menopause, 2021Abstract Genitourinary syndrome of menopause (GSM) is a highly prevalent and progressive condition of postmenopausal women that has significant negative effects on vulvovaginal health, sexual health, and overall quality of life. Despite many available safe and effective therapies, GSM often goes undiagnosed and untreated.
Susan Kellogg, Spadt, Lisa C, Larkin
openaire +2 more sources
Genitourinary Syndrome of Menopause
Clinical Obstetrics & Gynecology, 2018Genitourinary syndrome of menopause (GSM) describes a collection of exam findings and bothersome symptoms associated with estrogen deficiency involving changes to the labia, introitus, clitoris, vagina, urethra, and bladder. Vulvovaginal atrophy is a component of GSM.
openaire +4 more sources
Hormonal Medications for Genitourinary Syndrome of Menopause
Clinical Obstetrics & Gynecology, 2023Genitourinary syndrome of menopause is a common, under-reported, and undertreated chronic progressive condition requiring long-term treatment. Hypoestrogenism in the urogenital tissues is associated with bothersome dyspareunia, vulvovaginal symptoms, overactive bladder, and frequent urinary tract infections. Vaginal hormone therapies, including vaginal
JoAnn V, Pinkerton +2 more
openaire +2 more sources
Genitourinary Syndrome of Menopause: Prevalence and Predictors
Clinical Obstetrics & Gynecology, 2023The genitourinary syndrome of menopause (GSM) has been proposed as a diagnosis by a consensus of clinicians and investigators. Our purpose for this paper is to review extant evidence about: 1) the breadth of symptoms and symptom clusters as related to the syndrome; 2) the prevalence of GSM (includes vulvar and vaginal atrophy); 3) factors that are ...
NANCY F. WOODS +2 more
openaire +2 more sources